(IFF) International Flavors - Overview

Sector: Basic Materials | Industry: Specialty Chemicals | Exchange: NYSE (USA) | Market Cap: 17.878m USD | Total Return: 1.1% in 12m

Flavors, Fragrances, Ingredients, Enzymes, Excipients

Total Rating 42

Safety 57

Buy Signal 0.20

Specialty Chemicals
Industry Rotation: +12.7

Market Cap: 17.9B
Avg Turnover: 108M USD

ATR: 3.25%
Peers RS (IBD): 50.0

Risk 5d forecast

Volatility27.1%

Rel. Tail Risk-7.56%

Reward TTM

Sharpe Ratio0.06

Alpha-14.04

Character TTM

Beta0.612

Beta Downside0.699

Drawdowns 3y

Max DD42.62%

CAGR/Max DD-0.14

EPS (Earnings per Share)

EPS CAGR: -18.08%
EPS Trend: -41.1%

Last SUE: -0.21
Qual. Beats: 0

Revenue

Rev. CAGR: -5.70%
Rev. Trend: -82.3%

Last SUE: 1.88
Qual. Beats: 3

Warnings

High Debt/EBITDA (7.5) with thin interest coverage (-0.7)

Interest Coverage Ratio -0.7 is critical

Altman Z'' -0.49 < 1.0 - financial distress zone

Tailwinds

No distinct edge detected

Description: IFF International Flavors

International Flavors & Fragrances Inc. (NYSE: IFF) is a global specialty-chemicals company that develops and sells ingredients across four segments: Nourish (natural-based food ingredients and flavorings), Health & Biosciences (enzymes, cultures, and animal-nutrition solutions), Scent (fragrance compounds), and Pharma Solutions (cellulosic and seaweed-derived excipients). Headquartered in New York and operating in the U.S., Europe, and beyond, IFF leverages its extensive R&D platform to serve food-and-beverage, personal-care, and pharmaceutical markets.

In its most recent fiscal year (FY 2025), IFF reported net sales of $10.9 billion, up 7% year-over-year, with an adjusted earnings-per-share of $6.68 and an operating margin of 15.2%. The Nourish segment drove the bulk of growth, posting a 9% sales increase, largely on plant-based protein and clean-label flavor solutions. Free cash flow reached $1.2 billion, supporting a 4% dividend yield and a $3 billion share-repurchase program.

Key sector drivers include the accelerating consumer shift toward natural and sustainable ingredients-global plant-based protein demand is projected to grow at a 12% CAGR through 2030-and the expanding fragrance market, which is expected to reach $55 billion by 2027, fueled by premium personal-care and home-fragrance trends. IFF’s focus on bio-based technologies and strategic acquisitions positions it to capture a larger share of these growth tails.

For a deeper dive, you might explore ValueRay’s analyst notes on IFF.

Headlines to Watch Out For

Global consumer demand for packaged food and beverages impacts revenue
Commodity price fluctuations affect input costs for ingredients
Regulatory changes in food and fragrance industries pose compliance risks
Innovation in natural and sustainable ingredients drives market share
Currency exchange rate volatility impacts international sales and profits

Piotroski VR‑10 (Strict) 4.0

Net Income: -348.0m TTM > 0 and > 6% of Revenue
FCF/TA: 0.01 > 0.02 and ΔFCF/TA -1.10 > 1.0
NWC/Revenue: 15.25% < 20% (prev 31.87%; Δ -16.62% < -1%)
CFO/TA 0.03 > 3% & CFO 850.0m > Net Income -348.0m
Net Debt (6.06b) to EBITDA (809.0m): 7.49 < 3
Current Ratio: 1.42 > 1.5 & < 3
Outstanding Shares: last quarter (257.0m) vs 12m ago 0.39% < -2%
Gross Margin: 34.93% > 18% (prev 0.36%; Δ 3.46k% > 0.5%)
Asset Turnover: 40.18% > 50% (prev 40.06%; Δ 0.12% > 0%)
Interest Coverage Ratio: -0.67 > 6 (EBITDA TTM 809.0m / Interest Expense TTM 229.0m)

Altman Z'' -0.49

A: 0.07 (Total Current Assets 5.59b - Total Current Liabilities 3.93b) / Total Assets 25.54b
B: -0.13 (Retained Earnings -3.42b / Total Assets 25.54b)
C: -0.01 (EBIT TTM -153.0m / Avg Total Assets 27.10b)
D: -0.42 (Book Value of Equity -4.81b / Total Liabilities 11.35b)
Altman-Z'' Score: -0.49 = B

Beneish M -3.00

DSRI: 1.07 (Receivables 2.00b/1.97b, Revenue 10.89b/11.48b)
GMI: 1.03 (GM 34.93% / 35.91%)
AQI: 1.05 (AQ_t 0.60 / AQ_t-1 0.57)
SGI: 0.95 (Revenue 10.89b / 11.48b)
TATA: -0.05 (NI -348.0m - CFO 850.0m) / TA 25.54b)
Beneish M-Score: -3.00 (Cap -4..+1) = A

What is the price of IFF shares? As of April 13, 2026, the stock is trading at USD 72.52 with a total of 896,950 shares traded.
Over the past week, the price has changed by +0.96%, over one month by +4.20%, over three months by +5.78% and over the past year by +1.10%.

Is IFF a buy, sell or hold? International Flavors has received a consensus analysts rating of 4.14. Therefore, it is recommended to buy IFF.

StrongBuy: 10
Buy: 7
Hold: 4
Sell: 0
StrongSell: 1

What are the forecasts/targets for the IFF price?

Analysts Target Price	90.9	25.4%

International Flavors (IFF) - Fundamental Data Overview as of 09 April 2026

P/E Forward = 16.0256
P/S = 1.6417
P/B = 1.3071
P/EG = 0.8303
Revenue TTM = 10.89b USD
EBIT TTM = -153.0m USD
EBITDA TTM = 809.0m USD
Long Term Debt = 4.74b USD (from longTermDebt, last quarter)
Short Term Debt = 1.36b USD (from shortTermDebt, last quarter)
Debt = 6.65b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.06b USD (from netDebt column, last quarter)
Enterprise Value = 23.94b USD (17.88b + Debt 6.65b - CCE 590.0m)
Interest Coverage Ratio = -0.67 (Ebit TTM -153.0m / Interest Expense TTM 229.0m)
EV/FCF = 93.51x (Enterprise Value 23.94b / FCF TTM 256.0m)
FCF Yield = 1.07% (FCF TTM 256.0m / Enterprise Value 23.94b)
FCF Margin = 2.35% (FCF TTM 256.0m / Revenue TTM 10.89b)
Net Margin = -3.20% (Net Income TTM -348.0m / Revenue TTM 10.89b)
Gross Margin = 34.93% ((Revenue TTM 10.89b - Cost of Revenue TTM 7.09b) / Revenue TTM)
Gross Margin QoQ = 29.20% (prev 36.49%)
Tobins Q-Ratio = 0.94 (Enterprise Value 23.94b / Total Assets 25.54b)
Interest Expense / Debt = 0.74% (Interest Expense 49.0m / Debt 6.65b)
Taxrate = 18.18% (4.00m / 22.0m)
NOPAT = -125.2m (EBIT -153.0m * (1 - 18.18%)) [loss with tax shield]
Current Ratio = 1.42 (Total Current Assets 5.59b / Total Current Liabilities 3.93b)
Debt / Equity = 0.47 (Debt 6.65b / totalStockholderEquity, last quarter 14.15b)
Debt / EBITDA = 7.49 (Net Debt 6.06b / EBITDA 809.0m)
Debt / FCF = 23.68 (Net Debt 6.06b / FCF TTM 256.0m)
Total Stockholder Equity = 13.99b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.28% (Net Income -348.0m / Total Assets 25.54b)
RoE = -2.49% (Net Income TTM -348.0m / Total Stockholder Equity 13.99b)
RoCE = -0.82% (EBIT -153.0m / Capital Employed (Equity 13.99b + L.T.Debt 4.74b))
RoIC = -0.60% (negative operating profit) (NOPAT -125.2m / Invested Capital 20.87b)
WACC = 6.09% (E(17.88b)/V(24.53b) * Re(8.13%) + D(6.65b)/V(24.53b) * Rd(0.74%) * (1-Tc(0.18)))
Discount Rate = 8.13% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.39%
[DCF] Terminal Value 80.33% ; FCFF base≈394.4m ; Y1≈258.9m ; Y5≈118.4m
[DCF] Fair Price = N/A (negative equity: EV 3.66b - Net Debt 6.06b = -2.40b; debt exceeds intrinsic value)
EPS Correlation: -41.08 | EPS CAGR: -18.08% | SUE: -0.21 | # QB: 0
Revenue Correlation: -82.25 | Revenue CAGR: -5.70% | SUE: 1.88 | # QB: 3
EPS next Quarter (2026-06-30): EPS=1.17 | Chg7d=-0.003 | Chg30d=-0.012 | Revisions Net=+0 | Analysts=12
EPS current Year (2026-12-31): EPS=4.44 | Chg7d=-0.007 | Chg30d=-0.007 | Revisions Net=+0 | Growth EPS=+5.7% | Growth Revenue=-1.8%
EPS next Year (2027-12-31): EPS=4.80 | Chg7d=-0.008 | Chg30d=-0.008 | Revisions Net=+0 | Growth EPS=+8.0% | Growth Revenue=+3.0%
[Analyst] Revisions Ratio: +0.00 (3 Up / 3 Down within 30d for Next Quarter)

External Resources

Dataroma Stockcircle